Sienna Diagnostics Calls Notting Hill Home

26 June 2020

  • Sienna relocates to 23 Normanby Road, Notting Hill.
  • Sienna leaves the STC precinct after a successful 5 years.
  1. Development, commercialisation and launch of the hTERT IVD in the USA (2016)
  2. Successful registrations and l istings with the FDA, TGA and CE mark certifications
  3. Global expansion of our hTERT IVD distribution network (12 regions and counting)
  4. Successful IPO and listing with the ASX in 2017 (ASC:SDX)
  5. Acquisition of unique liquid biopsy and exosome isolation technology

Change of Registered Office

Melbourne, Australia, 26 June 2020: Sienna Cancer Diagnostics (ASX: SDX) (“Sienna” or “the Company”) advises that effective from today, the principal and registered office of the Company has changed to:

23 Normanby Rd
Notting Hill, Victoria 3168


For Further Information, please contact:
Carl Stubbings, CEO & Managing Director
Sienna Cancer Diagnostics Ltd
+61 3 9548 7586

The release of this announcement was authorised by Tony Di Pietro, Company Secretary.


News & opinion

Member Directory